GentiBio snags $20m seed

GentiBio Inc, an emerging biotherapeutics company, has raised $20 million in seed funding.

GentiBio Inc, an emerging biotherapeutics company, has raised $20 million in seed funding. OrbiMed, Novartis Venture Fund and RA Capital Management LP led the round.

Source: Press Release